Roman Vydzhak

Dr. Roman Vydzhak

V.P. Kukhar Institute of Bioorganic Chemistry and Petrochemistry (IBOPC) of the National Academy of Sciences of Ukraine
orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2021 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
AAAndrea Angeli
Andrea Angeli
VKViktor Georgievich Kartsev
Viktor Georgievich Kartsev
APAnthi Petrou
Anthi Petrou
Mariana PintealaMariana Pinteala
Mariana Pinteala
RVRoman Vydzhak
Roman Vydzhak
Claudiu SupuranClaudiu Supuran
Claudiu Supuran
Carbonic Anhydrases (CAs) are ubiquitous metalloenzymes involved in several disease conditions. There are 15 human CA (hCA) isoforms and their high homology represents a challenge for the discovery of potential drugs devoid of off-target side effects. For this reason, many synthetic and pharmacologic research efforts are underway to achieve the full pharmacological potential of CA modulators of activity. We report here a novel series of sulfanilamide derivatives containing heterocyclic carboxamide moieties which were evaluated as CA inhibitors against the physiological relevant isoforms hCA I, II, IX, and XII. Some of them showed selectivity toward isoform hCA II and hCA XII. Molecular docking was performed for some of these compounds on isoforms hCA II and XII to understand the possible interaction with the active site amino acid residues, which rationalized the reported inhibitory activity.

20 November 2021 in Molecules
Verified
Journal Article
Open access
PDF file
AAAndrea Angeli
Andrea Angeli
VKViktor Georgievich Kartsev
Viktor Georgievich Kartsev
APAnthi Petrou
Anthi Petrou
Mariana PintealaMariana Pinteala
Mariana Pinteala
VBVolodymyr S. Brovarets
Volodymyr S. Brovarets
Claudiu SupuranClaudiu Supuran
Claudiu Supuran
A series of benzenesulfonamides incorporating pyrazole- and pyridazinecarboxamides decorated with several bulky moieties has been obtained by original procedures. The new derivatives were investigated for the inhibition of four physiologically crucial human carbonic anhydrase (hCA, EC 4.2.2.1.1) isoforms, hCA I and II (cytosolic enzymes) as well as hCA IX and XII (transmembrane, tumor-associated isoforms). Examples of isoform-selective inhibitors were obtained for all four enzymes investigated here, and a computational approach was employed for explaining the observed selectivity, which may be useful in drug design approaches for obtaining inhibitors with pharmacological applications useful as antiglaucoma, diuretic, antitumor or anti-cerebral ischemia drugs.

1 January 1994 in Tetrahedron
Verified
Journal Article
Closed access
LMLuc Van Meervelt
Luc Van Meervelt
RVRoman Vydzhak
Roman Vydzhak
VBVladimir S. Brovarets
Vladimir S. Brovarets
NMNikolai I. Mishchenko
Nikolai I. Mishchenko
BDBoris S. Drach
Boris S. Drach

1 October 2006 in Russian Journal of General Chemistry
Verified
Journal Article
Closed access
PDF file
RVRoman Vydzhak
Roman Vydzhak
SPSvitlana Panchyshyn
Svitlana Panchyshyn


30 June 2020 in Ukrainica Bioorganica Acta
Verified
Journal Article
Open access
RVRoman Vydzhak
Roman Vydzhak
MKMaryna Kachaeva
Maryna Kachaeva
SPStepan Pilyo
Stepan Pilyo
VMViktoriia Moskvina
Viktoriia Moskvina
OSOlga Shablykina
Olga Shablykina
VBVolodymyr S. Brovarets
Volodymyr S. Brovarets
A versatile and efficient three-component cyclization of methyl 4-(o-hydroxyphenyl)-2,4-dioxobutanoates 1, N-substituted isatins 2, and primary amines 3 was explored to synthesize of 2H-spiro[chromeno[2,3-c]pyrrole-1,3'-indoline]-2',3,9-triones. We obtained a library of 122 derivatives with an indolin-2-one motif as an important structural fragment in natural alkaloids. This method is practical and useful strategy for constructing dihydrochromeno[2,3-c]pyrrole-3,9-diones. Most of the obtained products also have functional groups for easy and further diversification by classical reactions.